Difelikefalin Completed Phase 3 Trials for Uremic Pruritus Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04711603A Phase III Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.
NCT03998163CR845-CLIN3105: A Study to Evaluate the Safety and Effectiveness of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
NCT03636269CR845-CLIN3103: A Global Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
NCT03422653A Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus (KALM-1)
NCT03281538Extension Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus